Accordingly, mitofusin 2 (MFN2) that medicate mitochondrial fusion and OXPHOS is distinctly upregulated in surviving leukemia cells while the knockout of MFN2 rendered Jurkat sensitivity to DOX [183]. Here, MFN2 is linked to leukemia.